A return to ‘pre-pandemic levels’

business matching - connecting puzzle elements
Shortages of intravenous and subcutaneous Actemra have been resolved as pharmacists thanked for their patience A shortage of Actemra (tocilizumab) has finally been resolved after supply was battered following recommendations last year by the World Health Organisation (WHO) for the drug to be used as a treatment for patients seriously ill COVID-19. In July last

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘He’s not an expert in diagnosis, he’s not an expert in management.’
Next Back on the calendar